Ser59
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.8.2
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser59  -  P311 (human)

Site Information
LGSSELRsPRISYLH   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 457551

In vivo Characterization
Methods used to characterize site in vivo:
mutation of modification site ( 1 ) , phospho-antibody ( 1 ) , western blotting ( 1 )
Disease tissue studied:
brain cancer ( 1 ) , glioblastoma ( 1 ) , glioblastoma multiforme ( 1 ) , glioma ( 1 )
Relevant cell line - cell type - tissue:
T98G (glial) ( 1 ) , U-118MG (glial) ( 1 )

Upstream Regulation
Putative in vivo kinases:
PKCE (human) ( 1 ) , PKCZ (human) ( 1 )

Downstream Regulation
Effects of modification on P311:
protein degradation ( 1 )
Effects of modification on biological processes:
cell adhesion, altered ( 1 ) , cell motility, altered ( 1 )

References 

1

McDonough WS, Tran NL, Berens ME (2005) Regulation of glioma cell migration by serine-phosphorylated P311. Neoplasia 7, 862-72
16229809   Curated Info

PhosphoSitePlus® is a registered trademark of Cell Signaling Technology.
Use of PSP data is subject to a formal license agreement. Learn more

©2003-2025 Cell Signaling Technology, Inc.